FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1985496103> ?p ?o ?g. }

• W1985496103 abstract "Summary Triple therapy using telaprevir or boceprevir [hepatitis C virus ( HCV )‐ NS 3/ NS 4 A protease inhibitors ( PI )] in association with PEG ‐ IFN /ribavirin has recently become the new standard of care ( SOC ) for treatment of HCV genotype 1 patients. Our objective was to assess the efficacy and tolerance of triple therapy in routine clinical practice. A total of 186 consecutive HCV patients initiating triple therapy were enrolled in a single centre study. Clinical, biological and virological data were collected at baseline and during follow‐up as well as tolerance and side effect details. Among 186 HCV patients initiating triple therapy, 69% received telaprevir and 31% boceprevir. Sixty‐one per cent of patients had cirrhosis. The overall extended rapid virological response (e RVR ) rate and sustained virological response ( SVR ) rate were 57.0% and 59.7%, respectively. IL 28 B CC phenotype was associated with increased probability of achieving e RVR and SVR , whereas previous non‐response was associated with low e RVR and SVR rates. The SVR rate increased from 30.8% in previously non‐responders to 59.1% in partial non‐responders and 75% in relapsers. SVR rate in naive patients was 62.5%. Glomerular filtration rate assessed by MDRD after 12 weeks of therapy was significantly reduced for both PI ( P < 0.001). The model for end‐stage liver disease ( MELD ) score was significantly increased at W 12 for telaprevir ( P = 0.008) and at W 24 for boceprevir ( P = 0.027). PI ‐based triple therapy leads to high rates of virological response even in previously non‐responder patients. Renal function after triple therapy is impaired as well as MELD score in all patients. Cautious clinical monitoring should focus not only on haematological and dermatological side effects but also on renal function." @default.
• W1985496103 created "2016-06-24" @default.
• W1985496103 creator A5015051777 @default.
• W1985496103 creator A5018268108 @default.
• W1985496103 creator A5034012195 @default.
• W1985496103 creator A5042462482 @default.
• W1985496103 creator A5043045278 @default.
• W1985496103 creator A5059226303 @default.
• W1985496103 creator A5063172143 @default.
• W1985496103 creator A5068762264 @default.
• W1985496103 creator A5091050395 @default.
• W1985496103 date "2014-02-25" @default.
• W1985496103 modified "2023-10-08" @default.
• W1985496103 title "Boceprevir and telaprevir-based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end-stage liver disease score" @default.
• W1985496103 cites W1542338870 @default.
• W1985496103 cites W1971169339 @default.
• W1985496103 cites W1984052453 @default.
• W1985496103 cites W2003104968 @default.
• W1985496103 cites W2017557941 @default.
• W1985496103 cites W2019946868 @default.
• W1985496103 cites W2020914906 @default.
• W1985496103 cites W2025381309 @default.
• W1985496103 cites W2026614040 @default.
• W1985496103 cites W2027498662 @default.
• W1985496103 cites W2027545702 @default.
• W1985496103 cites W2030439961 @default.
• W1985496103 cites W2040117569 @default.
• W1985496103 cites W2046658390 @default.
• W1985496103 cites W2055864845 @default.
• W1985496103 cites W2059105505 @default.
• W1985496103 cites W2063285149 @default.
• W1985496103 cites W2079103647 @default.
• W1985496103 cites W2084845831 @default.
• W1985496103 cites W2086414517 @default.
• W1985496103 cites W2099823373 @default.
• W1985496103 cites W2103742920 @default.
• W1985496103 cites W2107512529 @default.
• W1985496103 cites W2111044696 @default.
• W1985496103 cites W2125963799 @default.
• W1985496103 cites W2127685726 @default.
• W1985496103 cites W2132290252 @default.
• W1985496103 cites W2141777445 @default.
• W1985496103 cites W2143559032 @default.
• W1985496103 cites W2161640919 @default.
• W1985496103 cites W64271499 @default.
• W1985496103 doi "https://doi.org/10.1111/jvh.12237" @default.
• W1985496103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24612466" @default.
• W1985496103 hasPublicationYear "2014" @default.
• W1985496103 type Work @default.
• W1985496103 sameAs 1985496103 @default.
• W1985496103 citedByCount "26" @default.
• W1985496103 countsByYear W19854961032014 @default.
• W1985496103 countsByYear W19854961032015 @default.
• W1985496103 countsByYear W19854961032016 @default.
• W1985496103 countsByYear W19854961032017 @default.
• W1985496103 countsByYear W19854961032021 @default.
• W1985496103 crossrefType "journal-article" @default.
• W1985496103 hasAuthorship W1985496103A5015051777 @default.
• W1985496103 hasAuthorship W1985496103A5018268108 @default.
• W1985496103 hasAuthorship W1985496103A5034012195 @default.
• W1985496103 hasAuthorship W1985496103A5042462482 @default.
• W1985496103 hasAuthorship W1985496103A5043045278 @default.
• W1985496103 hasAuthorship W1985496103A5059226303 @default.
• W1985496103 hasAuthorship W1985496103A5063172143 @default.
• W1985496103 hasAuthorship W1985496103A5068762264 @default.
• W1985496103 hasAuthorship W1985496103A5091050395 @default.
• W1985496103 hasConcept C126322002 @default.
• W1985496103 hasConcept C159641895 @default.
• W1985496103 hasConcept C203014093 @default.
• W1985496103 hasConcept C2522874641 @default.
• W1985496103 hasConcept C2776408679 @default.
• W1985496103 hasConcept C2776455275 @default.
• W1985496103 hasConcept C2776461080 @default.
• W1985496103 hasConcept C2776999253 @default.
• W1985496103 hasConcept C2777075537 @default.
• W1985496103 hasConcept C2777159539 @default.
• W1985496103 hasConcept C2778159067 @default.
• W1985496103 hasConcept C2780040827 @default.
• W1985496103 hasConcept C71924100 @default.
• W1985496103 hasConcept C90924648 @default.
• W1985496103 hasConceptScore W1985496103C126322002 @default.
• W1985496103 hasConceptScore W1985496103C159641895 @default.
• W1985496103 hasConceptScore W1985496103C203014093 @default.
• W1985496103 hasConceptScore W1985496103C2522874641 @default.
• W1985496103 hasConceptScore W1985496103C2776408679 @default.
• W1985496103 hasConceptScore W1985496103C2776455275 @default.
• W1985496103 hasConceptScore W1985496103C2776461080 @default.
• W1985496103 hasConceptScore W1985496103C2776999253 @default.
• W1985496103 hasConceptScore W1985496103C2777075537 @default.
• W1985496103 hasConceptScore W1985496103C2777159539 @default.
• W1985496103 hasConceptScore W1985496103C2778159067 @default.
• W1985496103 hasConceptScore W1985496103C2780040827 @default.
• W1985496103 hasConceptScore W1985496103C71924100 @default.
• W1985496103 hasConceptScore W1985496103C90924648 @default.
• W1985496103 hasIssue "9" @default.
• W1985496103 hasLocation W19854961031 @default.
• W1985496103 hasLocation W19854961032 @default.
• W1985496103 hasOpenAccess W1985496103 @default.
• W1985496103 hasPrimaryLocation W19854961031 @default.
• W1985496103 hasRelatedWork W1973380676 @default.

• next